Home / Market News / $TMO
fiscal.ai Corporate Catalyst Impact 55/100 ● negative

Evercore ISI Adjusts Thermo Fisher Scientific Price Target

Oct 28, 2026, 3:02 PM UTC · Primary ticker $TMO

Evercore ISI has lowered its price target for Thermo Fisher Scientific Inc. from $720 to $615. This adjustment reflects a revised valuation assessment by the analyst firm, indicating a potentially less optimistic outlook on the company's future performance or market conditions.

Evercore ISI, an analyst firm, has reduced its price target for Thermo Fisher Scientific (TMO) from $720 to $615. This action signals a less favorable valuation assessment by the firm, which could be due to various factors such as revised earnings expectations, changes in market multiples, or a shift in the perceived growth trajectory of the company. For traders, this is a short-term negative signal as it may lead to downward pressure on the stock price, especially if other analysts follow suit or if the market interprets this as a sign of underlying issues. The long-term implications depend on whether this revaluation reflects fundamental changes in TMO's business or broader sector trends. A key risk for traders is potential further downside if the market reacts strongly to this revised outlook.

$TMO negative Analyst price target reduction
Source: fiscal.ai
Join the waitlist for full signal validation →

Not financial advice. AI-generated analysis for informational purposes only.